市场调查报告书
商品编码
1291601
光遗传学市场:2023-2028年全球行业趋势、份额、规模、增长、机会和预测Optogenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 |
全球光遗传学市场规模在2022年达到385亿美元。展望未来,IMARC集团预计,到2028年,市场规模将达到999亿美元,在2023-2028年期间表现出16.41%的增长率(CAGR)。
光遗传学是指一种科学方法,包括遗传学和光学技术的结合。它主要用于用光传感器控制和监测神经元和其他类型细胞的生物功能。这些信息提供了对个体行为和生理学的见解,包括运动、学习、记忆、导航、新陈代谢、呼吸和传感器处理。光遗传学通过揭示与各种疾病相关的细胞活动,如慢性疼痛、癫痫、帕金森病、中风、药物成瘾、强迫症(OCD)、社会功能障碍以及焦虑和抑郁症,帮助临床发现。由于这些应用,光遗传学在神经科学领域被广泛利用。
由于各种感染、疾病、遗传性疾病、先天性异常以及大脑、神经和脊髓损伤而导致的神经系统疾病的发病率越来越高,这是目前推动光遗传学市场发展的关键因素之一。与此相呼应,引入纤维耦合发光二极管(LED),将其纳入植入物,以实现不受束缚的光传递,是另一个主要的增长诱导因素。此外,神经连接、无线微芯片、传感器、细胞表型工具和各种成像工具,如计算机断层扫描(CT)、位置发射断层扫描(PET)和磁共振成像(MRI)的快速技术进步,以精确评估器官和组织以识别疾病,正在推动市场增长。由于光遗传治疗方法在细胞、空间和时间上的精确性,医护人员越来越倾向于光遗传治疗方法,这进一步促进了市场的增长。其他因素,包括医疗支出的增加,神经科学领域广泛的研究和开发(R&D)活动,以及主要参与者、制药公司和各国政府之间的战略合作,以实施有利的政策,支持推出治疗神经系统疾病的新药,正在为市场创造一个积极的前景。
The global optogenetics market size reached US$ 38.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 99.9 Billion by 2028, exhibiting a growth rate (CAGR) of 16.41% during 2023-2028.
Optogenetics refers to a scientific approach that includes a combination of genetics and optics technologies. It is primarily used for controlling and monitoring the biological functions of neurons and other types of cells with light sensors. This information provides insights into individual behavior and physiology, including movement, learning, memory, navigation, metabolism, respiration, and sensor processing. Optogenetics aids in clinical discoveries by shedding light on the cellular activities associated with various diseases, such as chronic pain, epilepsy, Parkinson disease, stroke, drug addiction, obsessive compulsion disorder (OCD), social dysfunction, and anxiety and depression. On account of these applications, optogenetics finds extensive utilization in the field of neurosciences.
The increasing prevalence of neurological disorders due to various infections, ailments, genetic disorders, congenital abnormalities, and brain, nerve, and spinal cord injuries is one of the key factors currently driving the optogenetics market growth. In line with this, the introduction of fiber-coupled light-emitting diode (LED) for being incorporated into the implants to enable the untethered light delivery is acting as another major growth-inducing factor. Additionally, rapid technological advancements in neural connectivity, wireless microchip, sensors, cell phenotyping tools, and various imaging tools, like computed tomography (CT), position emission tomography (PET), and magnetic resonance imaging (MRI) to precisely evaluate organs and tissues for identifying disorders is propelling the market growth. The rising inclination of healthcare professionals toward optogenetic therapeutic methodologies on account of its cellular, spatial, and temporal precision is further contributing to the market growth. Other factors, including increasing healthcare expenditure, extensive research and development (R&D) activities in the field of neurosciences, and strategic collaborations between key players, pharmaceutical companies, and governments of various nations to implement favorable policies that support the launch of novel drugs for treating neurological diseases, are creating a positive outlook for the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global optogenetics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on light equipment type, application and end user.
Light-emitting Diode (LED)
Laser
Neuroscience
Behavioral Tracking
Retinal Disease Treatment
Others
Hospitals
Clinics
Diagnostic
Research
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Addgene, Coherent Inc., Elliot Scientific Limited, GenSight Biologics S.A., HUBNER GmbH & Co KG, Judges Scientific plc, Laserglow Technologies, Noldus Information Technology, Regenxbio Inc., Shanghai Laser & Optics Century Co. Ltd, The Jackson Laboratory and Thorlabs Inc.
Key Questions Answered in This Report
1. What was the size of the global optogenetics market in 2022?
2. What is the expected growth rate of the global optogenetics market during 2023-2028?
3. What are the key factors driving the global optogenetics market?
4. What has been the impact of COVID-19 on the global optogenetics market?
5. What is the breakup of the global optogenetics market based on the light equipment type?
6. What is the breakup of the global optogenetics market based on the application?
7. What are the key regions in the global optogenetics market?
8. Who are the key players/companies in the global optogenetics market?